NeoGenix Biosciences at the Fakih IVF Reproductive Symposium 2026
Our Chief Scientific Officer, Dale, recently participated in the Fakih IVF Reproductive Symposium 2026 in Dubai, where he presented our work on SpermSearch.AI and engaged with clinicians, scientists, and IVF leaders from across the Gulf region and beyond.
The symposium brought together a highly motivated clinical and scientific community focused on practical advances in reproductive medicine. It was valuable to be part of a meeting where discussions were not just about new technology in principle, but about how innovation can be adopted in ways that improve real-world patient outcomes.
Presenting SpermSearch.AI for severe male factor infertility workflows
During the meeting, we shared our work on AI-assisted extended sperm search, with a focus on the challenge of identifying sperm in highly complex and low-yield samples such as non-obstructive azoospermia (NOA) and other severe male factor cases.
SpermSearch.AI is designed as a real-time assistive tool to support embryologists during extended sperm search workflows by helping localise sperm candidates within the live microscope field of view. The aim is not to replace expert judgement, but to assist trained laboratory professionals in one of the most time-intensive and demanding procedures in the IVF laboratory.
The strong interest and discussion around this topic reflected a broader shift occurring across IVF: laboratories are increasingly looking for tools that can integrate into existing workflows, reduce operational burden, and support better efficiency without compromising clinical oversight.
Productive conversations across the region
One of the most valuable aspects of the symposium was the opportunity to reconnect with familiar faces and meet new clinicians and scientists working at the forefront of reproductive care in the region.
Events like this are important because they create space for direct discussion about what laboratories actually need. In our conversations, there was clear interest in technologies that are not developed in isolation, but are instead built around genuine workflow problems faced by embryologists and andrology teams.
For NeoGenix, these discussions are essential to improve our products by learning more about what colleagues around the world actually want and need. They help ensure that our development remains grounded in the realities and struggles of clinical practice.
Moving forward
NeoGenix remains focused on building clinically relevant tools for IVF laboratories, particularly in areas where workflow complexity, time pressure, and sample scarcity create real operational challenges.
Our time in Dubai reinforced the importance of collaboration between technology developers, clinicians, and laboratory scientists. Progress in this field depends on close engagement with end users and on ensuring that innovation is matched by utility, usability, and clinical relevance.
We thank the organisers of the Fakih IVF Reproductive Symposium 2026 for hosting an excellent meeting and for bringing together a community committed to advancing reproductive medicine.
We look forward to continuing these discussions and supporting laboratories working to improve outcomes for patients facing severe male factor infertility.
